The Procter & Gamble Company
Every calculator, already run for PG
Open the full toolkit →You have the numbers on PG. Get the argument.
A written report on which of these readings actually decide the outcome for The Procter & Gamble Company, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
25 analysts covering PGAnalyst Price Target Disagreement for The Procter & Gamble Company
Wall Street's bull case implies +27% from the current price; the bear case implies -2%. Analysts are relatively aligned on PG's range.
Ownership & short interest
Insider Trading Activity for PG
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About The Procter & Gamble Company
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the…
PG — frequently asked
Is PG a buy right now?
Wall Street's consensus rating on The Procter & Gamble Company is Buy across 25 analysts, with a mean price target of $160.61 (+10% vs. the current $146.39). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is PG overvalued?
PG trades at 22.1x trailing earnings, against a DCF fair value of $222 per share. The current price implies 1% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is PG's next earnings date?
The Procter & Gamble Company is next scheduled to report earnings around Oct 22, 2026. A full PG research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for The Procter & Gamble Company?
Analysts covering The Procter & Gamble Company (PG) range from a bear-case target of $143.00 to a bull-case high of $186.00, with a mean consensus target of $160.61 across 23 analysts. The spread of $43.00 (29% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare The Procter & Gamble Company against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For The Procter & Gamble Company
Start with the evergreen guides that matter most for Consumer Defensive, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full PG research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on The Procter & Gamble Company, in minutes. 3 free reports included with every account — no credit card required.